The Quotes are Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.

Elekta Receives U.S. FDA 510(k) Clearance Following Launch of New Versa HD Radiation Therapy System for Cancer Treatment

Thursday, 11 April 2013
Human care company, Elekta announces that it has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States.
Featuring high precision beam shaping and tumour targeting and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.

“We are delighted to receive FDA clearance,” says Jay Hoey, Executive Vice President, Elekta North America. “The potential clinical benefits for patients are
significant. Further, the operational benefits for clinicians and providers are eagerly anticipated," the company reports in a press release.

The company adds that the groundbreaking linear accelerator provides single system versatility to deliver sophisticated treatments for more patients and cancer types.
Scancomark.com team

We welcome your contribution. Did you find anything wrong with this article? Do you want to contribute to our news network? Do have a news tip or assist us with a correction